MétaCan
Menu
← Back to cohort
Record W4409625431 · doi:10.1158/1538-7445.am2025-1619

Abstract 1619: The HIV protease inhibitor nelfinavir increases the sensitivity of epithelial ovarian cancer cells to cisplatin

2025· article· en· W4409625431 on OpenAlexaff
Benjamin N. Forgie, Sarah Tadhg Ferrier, Farah H. Abdalbari, Edith Zorychta, Alicia A. Goyeneche, Julia V. Burnier, Carlos Telleria

Bibliographic record

VenueCancer Research · 2025
Typearticle
Languageen
FieldMedicine
TopicViral-associated cancers and disorders
Canadian institutionsMcGill University Health CentreMcGill University
Fundersnot available
KeywordsNelfinavirCisplatinProtease inhibitor (pharmacology)Ovarian cancerCancer researchProteaseMedicineEpithelial ovarian cancerVirologyCancerPharmacologyHuman immunodeficiency virus (HIV)OncologyInternal medicineChemistryChemotherapyEnzymeBiochemistryAntiretroviral therapyViral load

Abstract

fetched live from OpenAlex

Abstract Chemotherapy resistance is a major challenge in epithelial ovarian cancer (EOC) treatment. Standard treatment involves cytoreductive surgery in combination with platinum (Pt)-based chemotherapy. While initial treatment is often successful, over 80% of patients develop recurrent Pt-resistant disease. Therefore, therapeutics which increase sensitivity to platinating agents such as CDDP are essential to kill EOC cells. One candidate drug that may increase the sensitivity of CDDP to resistant EOC cells is the HIV protease inhibitor nelfinavir (NFV), which has previously shown anti-cancer activity against EOC in vitro. The goal of this study was to determine if the combination of NFV and CDDP is effective against EOC cells. Four EOC cell lines, with varying degrees of CDDP resistance, were exposed to increasing concentrations of CDDP in the presence or absence of NFV. In all cell lines, the addition of NFV significantly enhanced the cytotoxicity and decreased the IC50 of CDDP. Furthermore, the combination of NFV and CDDP was determined to be synergistic using the Loewe model of drug interaction. Interestingly, EOC cells treated with NFV and CDDP displayed characteristics of lytic cell death, such as an increased proportion of annexin-V and 7-AAD co-staining, and the release of LDH into the culture supernatant. Additionally, morphological assessment with brightfield and fluorescent microscopy revealed significant cellular swelling and cytoplasmic vacuolization, signs of inflammatory cell death. Immunoblotting revealed cleavage of the pyroptotic effector proteins gasdermin D and gasdermin E, suggesting a shift from apoptosis to pyroptosis with NFV and CDDP combination. Further evidence for pyroptosis include cleavage of the inflammatory caspase-1, as well as release of the inflammatory cytokine IL-1β into the supernatant as determined through ELISA. Interestingly, the combination of CDDP and NFV resulted in decreased expression of mature lamin A, leading to severe nuclear deformation and increased DNA damage. Furthermore, the loss of lamin A was associated with the leakage of nuclear DNA into the cytosol, as analyzed through droplet digital PCR (ddPCR) after cellular fractionation. Cytosolic dsDNA is an activation signal for the AIM2 inflammasome; to confirm its involvement, EOC cells were incubated with CDDP and NFV in the presence or absence of the AIM2 inhibitor suramin. Addition of suramin to the CDDP and NFV treated EOC cells rescued cell viability, and simultaneously decreased IL-1β. Overall, these results demonstrate a transition from apoptotic to pyroptotic cell death when EOC are treated with CDDP and NFV. Resistance to apoptosis is a major mechanism by which EOC cells become Pt-resistant. Therefore, NFV and CDDP together, may be a feasible therapeutic option for these patients through the induction of pyroptosis. Citation Format: Benjamin Forgie, Sarah T. Ferrier, Farah H. Abdalbari, Edith Zorychta, Alicia A. Goyeneche, Julia V. Burnier, Carlos M. Telleria. The HIV protease inhibitor nelfinavir increases the sensitivity of epithelial ovarian cancer cells to cisplatin [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 1619.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Other · Consensus signal: none
Teacher disagreement score0.002
Threshold uncertainty score0.008

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.036
GPT teacher head0.374
Teacher spread0.339 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueCancer Research→Same topicViral-associated cancers and disorders→French-language works237,207→